Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pamrevlumab for the treatment of idiopathic pulmonary fibrosis.
Sgalla G, Franciosa C, Simonetti J, Richeldi L. Sgalla G, et al. Expert Opin Investig Drugs. 2020 Aug;29(8):771-777. doi: 10.1080/13543784.2020.1773790. Epub 2020 Jun 7. Expert Opin Investig Drugs. 2020. PMID: 32447983 Review.
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments.
De Biasi S, Cerri S, Bianchini E, Gibellini L, Persiani E, Montanari G, Luppi F, Carbonelli CM, Zucchi L, Bocchino M, Zamparelli AS, Vancheri C, Sgalla G, Richeldi L, Cossarizza A. De Biasi S, et al. Among authors: sgalla g. BMC Med. 2015 Nov 9;13:277. doi: 10.1186/s12916-015-0515-0. BMC Med. 2015. PMID: 26552487 Free PMC article.
Novel drug targets for idiopathic pulmonary fibrosis.
Sgalla G, Cocconcelli E, Tonelli R, Richeldi L. Sgalla G, et al. Expert Rev Respir Med. 2016 Apr;10(4):393-405. doi: 10.1586/17476348.2016.1152186. Epub 2016 Feb 26. Expert Rev Respir Med. 2016. PMID: 26854382
Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis.
Jones MG, Fabre A, Schneider P, Cinetto F, Sgalla G, Mavrogordato M, Jogai S, Alzetani A, Marshall BG, O'Reilly KM, Warner JA, Lackie PM, Davies DE, Hansell DM, Nicholson AG, Sinclair I, Brown KK, Richeldi L. Jones MG, et al. Among authors: sgalla g. JCI Insight. 2016 Apr 21;1(5):e86375. doi: 10.1172/jci.insight.86375. JCI Insight. 2016. PMID: 27275013 Free PMC article.
The safety of new drug treatments for idiopathic pulmonary fibrosis.
Fletcher S, Jones MG, Spinks K, Sgalla G, Marshall BG, Limbrey R, Richeldi L. Fletcher S, et al. Among authors: sgalla g. Expert Opin Drug Saf. 2016 Nov;15(11):1483-1489. doi: 10.1080/14740338.2016.1218470. Epub 2016 Aug 17. Expert Opin Drug Saf. 2016. PMID: 27532218 Review.
57 results